References: Principles of managing bipolar disorder in adults and young people

Austin M-P, Highet N, and the Expert Working Group . Mental health care in the perinatal period: Australian clinical practice guideline. Melbourne: Centre of Perinatal Excellence; 2017. https://www.cope.org.au/health-professionals/health-professionals-3/review-of-new-perinatal-mental-health-guidelines/
Bromley R, Weston J, Adab N, Greenhalgh J, Sanniti A, McKay AJ, et al. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. Cochrane Database Syst Rev 2014;(10):CD010236. https://www.ncbi.nlm.nih.gov/pubmed/25354543
Chisolm MS, Payne JL. Management of psychotropic drugs during pregnancy. BMJ 2016;532:h5918. https://www.ncbi.nlm.nih.gov/pubmed/26791406
Diav-Citrin O, Shechtman S, Tahover E, Finkel-Pekarsky V, Arnon J, Kennedy D, et al. Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study. Am J Psychiatry 2014;171(7):785–94. https://www.ncbi.nlm.nih.gov/pubmed/24781368
Fornaro M, Maritan E, Ferranti R, Zaninotto L, Miola A, Anastasia A, et al. Lithium exposure during pregnancy and the postpartum period: a systematic review and meta-analysis of safety and efficacy outcomes. Am J Psychiatry 2020;177(1):76–92. https://www.ncbi.nlm.nih.gov/pubmed/31623458
Goodwin GM, Haddad PM, Ferrier IN, Aronson JK, Barnes T, Cipriani A, et al. Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2016;30(6):495–553. https://www.ncbi.nlm.nih.gov/pubmed/26979387
Grande I, Berk M, Birmaher B, Vieta E. Bipolar disorder. Lancet 2016;387(10027):1561–72. https://www.ncbi.nlm.nih.gov/pubmed/26388529
Hiemke C, Bergemann N, Clement HW, Conca A, Deckert J, Domschke K, et al. Consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology: update 2017. Pharmacopsychiatry 2018;51(1-02):9–62. https://www.ncbi.nlm.nih.gov/pubmed/28910830
Malhi GS, Bassett D, Boyce P, Bryant R, Fitzgerald PB, Fritz K, et al. Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 2015;49(12):1087–206. https://www.ncbi.nlm.nih.gov/pubmed/26643054
McAllister-Williams RH, Baldwin DS, Cantwell R, Easter A, Gilvarry E, Glover V, et al. British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017. J Psychopharmacol 2017;31(5):519–52. https://www.ncbi.nlm.nih.gov/pubmed/28440103
Mitchell PB, Ball JR, Best JA, Gould BM, Malhi GS, Riley GJ, et al. The management of bipolar disorder in general practice. Med J Aust 2006;184(11):566–70. https://www.ncbi.nlm.nih.gov/pubmed/16768664
National Institute for Health and Care Excellence (NICE). Antenatal and postnatal mental health: clinical management and service guidance (cg192). London: NICE; 2014, updated 2018. https://www.nice.org.uk/guidance/cg192
National Institute for Health and Care Excellence (NICE). Bipolar disorder: assessment and management [cg185]. London: NICE; 2014 (updated 2020). https://www.nice.org.uk/guidance/cg185
Ornoy A, Koren G. SSRIs and SNRIs (SRI) in pregnancy: effects on the course of pregnancy and the offspring: how far are we from having all the answers? Int J Mol Sci 2019;20(10). https://www.ncbi.nlm.nih.gov/pubmed/31091646
Pariente G, Leibson T, Shulman T, Adams-Webber T, Barzilay E, Nulman I. Pregnancy outcomes following in utero exposure to lamotrigine: a systematic review and meta-analysis. CNS Drugs 2017;31(6):439–50. https://www.ncbi.nlm.nih.gov/pubmed/28434134
Pavlova B, Perlis RH, Mantere O, Sellgren CM, Isometsa E, Mitchell PB, et al. Prevalence of current anxiety disorders in people with bipolar disorder during euthymia: a meta-analysis. Psychol Med 2017;47(6):1107–15. https://www.ncbi.nlm.nih.gov/pubmed/27995827
Poels EMP, Bijma HH, Galbally M, Bergink V. Lithium during pregnancy and after delivery: a review. Int J Bipolar Disord 2018;6(1):26. https://www.ncbi.nlm.nih.gov/pubmed/30506447
Therapeutic Goods Administration (TGA). Potential risk of neurodevelopmental disorders in children born to men taking sodium valproate. Woden, ACT: TGA; 7 March 2025. https://www.tga.gov.au/news/safety-updates/potential-risk-neurodevelopmental-disorders-children-born-men-taking-sodium-valproate
Tomson T, Battino D, Bromley R, Kochen S, Meador K, Pennell P, et al. Management of epilepsy in pregnancy: a report from the International League Against Epilepsy Task Force on Women and Pregnancy. Epileptic Disord 2019;21(6):497–517. https://www.ncbi.nlm.nih.gov/pubmed/31782407
Vieta E, Berk M, Schulze TG, Carvalho AF, Suppes T, Calabrese JR, et al. Bipolar disorders. Nat Rev Dis Primers 2018;4:18008. https://www.ncbi.nlm.nih.gov/pubmed/29516993
Viguera AC, Whitfield T, Baldessarini RJ, Newport DJ, Stowe Z, Reminick A, et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. Am J Psychiatry 2007;164(12):1817–24; quiz 923. https://www.ncbi.nlm.nih.gov/pubmed/18056236
Wesseloo R, Kamperman AM, Munk-Olsen T, Pop VJ, Kushner SA, Bergink V. Risk of postpartum relapse in bipolar disorder and postpartum psychosis: a systematic review and meta-analysis. Am J Psychiatry 2016;173(2):117–27. https://www.ncbi.nlm.nih.gov/pubmed/26514657
Weston J, Bromley R, Jackson CF, Adab N, Clayton-Smith J, Greenhalgh J, et al. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane Database Syst Rev 2016;11:CD010224. https://www.ncbi.nlm.nih.gov/pubmed/27819746
Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord 2018;20(2):97–170. https://www.ncbi.nlm.nih.gov/pubmed/29536616